Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neoplasms 4Zollinger-Ellison Syndrome 1Unspecified Childhood Solid Tumor, Protocol Specific 1Somatostatinoma 1Sarcoma, Synovial 1Sarcoma 1Rhabdomyosarcoma 1Pinealoma 1Paraganglioma 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Malignant mesenchymal tumor 1Liposarcoma 1Leiomyosarcoma 1Insulinoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Glucagonoma 1Glioma 1Fibrosarcoma 1Desmoplastic Small Round Cell Tumor 1Dermatofibrosarcoma 1Chondrosarcoma, Extraskeletal Myxoid 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1Carcinoma, Hepatocellular 1Brain Stem Neoplasms 1Adult Solid Neoplasm 1

Interventions

selinexor 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Doxorubicin 2ribociclib 1pembrolizumab 1pegfilgrastim 1metarrestin 1ixazomib 1fludarabine phosphate 1fludarabine 1cixutumumab 1X-Rays 1Specimen Handling 1Radiation 1Photons 1Nivolumab 1Mesna 1Ifosfamide 1High-Energy Shock Waves 1Filgrastim 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Celecoxib 1Biopsy 1BO-112 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neurofibrosarcoma × cixutumumab × Clear all
NCT00720174 2016-05-17

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡